Daniel Vapnek

Daniel Vapnek

Corporate Officer/Principal presso
University of California, Santa Barbara
87 anni
Health Technology
Consumer Services

Profilo

Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).

Posizioni attive di Daniel Vapnek

SocietàPosizioneInizio
Corporate Officer/Principal -

Precedenti posizioni note di Daniel Vapnek

SocietàPosizioneFine
Direttore/Membro del Consiglio 01/04/2007
Protein Pathways, Inc.
Presidente 01/11/2004
ASPIRA WOMEN'S HEALTH INC. Direttore/Membro del Consiglio 01/05/2001
AMGEN INC. Direttore Tecnico/Scientifico/R&S 31/12/1996
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Daniel Vapnek

Formazione di Daniel Vapnek

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

84

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Protein Pathways, Inc.

  1. Mercati
  2. Insiders
  3. Daniel Vapnek